HUP9802091A2 - Idegátültetés pluripotens neuroepiteliális sejtek alkalmazásával - Google Patents
Idegátültetés pluripotens neuroepiteliális sejtek alkalmazásávalInfo
- Publication number
- HUP9802091A2 HUP9802091A2 HU9802091A HUP9802091A HUP9802091A2 HU P9802091 A2 HUP9802091 A2 HU P9802091A2 HU 9802091 A HU9802091 A HU 9802091A HU P9802091 A HUP9802091 A HU P9802091A HU P9802091 A2 HUP9802091 A2 HU P9802091A2
- Authority
- HU
- Hungary
- Prior art keywords
- neuroepithelial cells
- neural transplantation
- pluripotent neuroepithelial
- pluripotent
- cells
- Prior art date
Links
- 230000001537 neural effect Effects 0.000 title 1
- 210000000461 neuroepithelial cell Anatomy 0.000 title 1
- 238000002054 transplantation Methods 0.000 title 1
- 230000003542 behavioural effect Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C12N2501/392—Sexual steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/395—Thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/91—Heparin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Psychiatry (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
Abstract
A találmány tárgya plűripőtens neűrőepiteliális sejtek terápiásalkalmazásra, különösen viselkedési és/vagy pszichőlógiai zavarkezelésére. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9518606.0A GB9518606D0 (en) | 1995-09-12 | 1995-09-12 | Neural transplantation |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9802091A2 true HUP9802091A2 (hu) | 1998-12-28 |
HUP9802091A3 HUP9802091A3 (en) | 2001-01-29 |
Family
ID=10780583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9802091A HUP9802091A3 (en) | 1995-09-12 | 1996-09-12 | Neural transplantation using pluripotent neuroepithelial cells |
Country Status (21)
Country | Link |
---|---|
US (3) | US7048921B2 (hu) |
EP (1) | EP0850298B1 (hu) |
JP (1) | JP4280872B2 (hu) |
KR (1) | KR19990044606A (hu) |
CN (1) | CN1193345A (hu) |
AT (1) | ATE242316T1 (hu) |
AU (1) | AU711563B2 (hu) |
CA (1) | CA2231436C (hu) |
CZ (1) | CZ296669B6 (hu) |
DE (1) | DE69628566T2 (hu) |
DK (1) | DK0850298T3 (hu) |
ES (1) | ES2196172T3 (hu) |
GB (1) | GB9518606D0 (hu) |
HK (1) | HK1009154A1 (hu) |
HU (1) | HUP9802091A3 (hu) |
NO (1) | NO981072L (hu) |
PL (1) | PL186777B1 (hu) |
PT (1) | PT850298E (hu) |
RU (1) | RU2185833C2 (hu) |
SK (1) | SK285816B6 (hu) |
WO (1) | WO1997010329A1 (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ294906A (en) | 1994-11-08 | 2000-03-27 | Cellfactors Plc | Producing large population of neural cells and cell lines, typically human that are pleiotropic but will differentiate following specific treatment |
GB9518606D0 (en) | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
GB9904281D0 (en) * | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
GB9907243D0 (en) | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
KR100801764B1 (ko) * | 1999-09-17 | 2008-02-05 | 레뉴런 리미티드 | 세포의 조건부 불멸화 |
US6399384B1 (en) | 1999-09-17 | 2002-06-04 | Reneuron Limited | Conditional immortalization of cells |
US6465215B1 (en) | 1999-12-14 | 2002-10-15 | Reneuron Limited | Identification of cells for transplantation |
GB0005856D0 (en) * | 2000-03-10 | 2000-05-03 | Reneuron Ltd | Genetic constructs |
GB0125773D0 (en) * | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
ES2294650T3 (es) | 2004-09-30 | 2008-04-01 | Reneuron Limited | Linea celular. |
CA2725953A1 (en) * | 2007-05-29 | 2008-12-11 | Christopher B. Reid | Methods for production and uses of multipotent cell populations, pluripotent cell populations, neuronal cell populations, and muscle cell populations |
GB0822246D0 (en) | 2008-12-05 | 2009-01-14 | Reneuron Ltd | Composition |
GB0902034D0 (en) | 2009-02-06 | 2009-03-11 | Reneuron Ltd | Method |
GB201011589D0 (en) * | 2010-07-09 | 2010-08-25 | Reneuron Ltd | Therapeutic cells |
US20150232662A1 (en) * | 2014-02-20 | 2015-08-20 | Sabic Innovative Plastics Ip B.V. | Thermoplastic composition and article |
WO2015171928A2 (en) * | 2014-05-07 | 2015-11-12 | Joslin Diabetes Center, Inc. | Methods and compositions for induction of ucp1 expression |
CN116590345B (zh) * | 2023-05-06 | 2024-01-30 | 北京中医药大学 | 永生化小鼠足细胞系及其制备方法、分化方法和应用 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US28510A (en) * | 1860-05-29 | John e | ||
US1662A (en) * | 1840-06-27 | ariel nobris | ||
US203483A (en) * | 1878-05-07 | Improvement in honey-boxes | ||
US146821A (en) * | 1874-01-27 | Improvement in nose-pieces of nail-plate feeders | ||
US147873A (en) * | 1874-02-24 | Improvement in nasal yokes for animals | ||
US913443A (en) * | 1908-08-13 | 1909-02-23 | Webster Full Expansion Rotary Engine Company | Rotary engine. |
NZ226750A (en) * | 1987-10-29 | 1990-09-26 | Amrad Corp Ltd | Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene |
WO1989009816A1 (en) | 1988-04-12 | 1989-10-19 | Massachusetts Institute Of Technology | Method for manipulation of the cell types of eukaryotes |
US5270191A (en) | 1988-04-12 | 1993-12-14 | Massachusetts Institute Of Technology | Method for manipulation of the cell types of eukaryotes |
US5070191A (en) * | 1989-04-27 | 1991-12-03 | Ajinomoto Co., Inc. | Demethylallosamidin and a process for production thereof |
US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
WO1991009936A1 (en) * | 1989-12-26 | 1991-07-11 | Hana Biologics, Inc. | Proliferated neuron progenitor cell product and process |
US5612211A (en) * | 1990-06-08 | 1997-03-18 | New York University | Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
RU2028089C1 (ru) * | 1990-10-16 | 1995-02-09 | Украинский научно-исследовательский институт нейрохирургии | Способ лечения апаллического синдрома |
US5851832A (en) * | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
EP0594669B9 (en) * | 1991-07-08 | 2008-03-19 | NeuroSpheres Holdings Ltd. | Growth factor-responsive neural progenitor cells which can be proliferated in vitro. |
JPH07504331A (ja) | 1992-03-04 | 1995-05-18 | システミックス,インコーポレイティド | 造血幹細胞の培養およびその遺伝子工学 |
US5753491A (en) * | 1993-04-13 | 1998-05-19 | Us Health | Use of neuro-derived fetal cell lines for transplantation therapy |
DE69429721T2 (de) * | 1993-04-13 | 2002-09-05 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Rockville | Verwendung von neuronalen fötalen zellinien für transplantationstherapie |
NZ294906A (en) * | 1994-11-08 | 2000-03-27 | Cellfactors Plc | Producing large population of neural cells and cell lines, typically human that are pleiotropic but will differentiate following specific treatment |
AU716811B2 (en) * | 1994-11-14 | 2000-03-09 | Neurospheres Holdings Ltd | Regulation of neural stem cell proliferation |
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
GB9517263D0 (en) | 1995-08-23 | 1995-10-25 | Cancer Res Campaign Tech | Expression systems |
GB9518606D0 (en) * | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
US5588692A (en) | 1995-10-11 | 1996-12-31 | General Motors Corporation | Push-out vehicle side door |
JP2001500725A (ja) | 1996-08-19 | 2001-01-23 | ユニヴァーシティー オヴ マサチューセッツ | 種間核移植により製造される胚性または幹細胞様細胞株 |
SE9604322D0 (sv) * | 1996-11-25 | 1996-11-25 | Astra Ab | Bacterial antigens and vaccine compositions II |
US20020123143A1 (en) | 1997-08-22 | 2002-09-05 | Jean Toma | Multipotent stem cells from peripheral tissues and uses thereof |
ES2246085T3 (es) * | 1998-05-07 | 2006-02-01 | University Of South Florida | Celulas de medula osea como fuente de neuronas util para reparar la medula espinal y el cerebro. |
US5958767A (en) * | 1998-08-14 | 1999-09-28 | The Children's Medical Center Corp. | Engraftable human neural stem cells |
GB9904281D0 (en) | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
GB9907243D0 (en) * | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
US6399384B1 (en) * | 1999-09-17 | 2002-06-04 | Reneuron Limited | Conditional immortalization of cells |
US6465215B1 (en) | 1999-12-14 | 2002-10-15 | Reneuron Limited | Identification of cells for transplantation |
US7160724B2 (en) | 2000-03-09 | 2007-01-09 | University Of South Florida | Human cord blood as a source of neural tissue for repair of the brain and spinal cord |
US7250294B2 (en) | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
AU2001264763A1 (en) | 2000-06-05 | 2001-12-17 | University Of South Florida | Human mesenchymal progenitor cell |
US7049072B2 (en) | 2000-06-05 | 2006-05-23 | University Of South Florida | Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state |
WO2003029432A2 (en) | 2001-10-03 | 2003-04-10 | University Of South Florida | Human mesenchymal progenitor cell |
GB0125773D0 (en) | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
ES2294650T3 (es) * | 2004-09-30 | 2008-04-01 | Reneuron Limited | Linea celular. |
-
1995
- 1995-09-12 GB GBGB9518606.0A patent/GB9518606D0/en active Pending
-
1996
- 1996-09-12 PL PL96325646A patent/PL186777B1/pl unknown
- 1996-09-12 DE DE69628566T patent/DE69628566T2/de not_active Expired - Lifetime
- 1996-09-12 WO PCT/GB1996/002251 patent/WO1997010329A1/en active IP Right Grant
- 1996-09-12 DK DK96930260T patent/DK0850298T3/da active
- 1996-09-12 CZ CZ0055898A patent/CZ296669B6/cs not_active IP Right Cessation
- 1996-09-12 AU AU69375/96A patent/AU711563B2/en not_active Expired
- 1996-09-12 ES ES96930260T patent/ES2196172T3/es not_active Expired - Lifetime
- 1996-09-12 EP EP96930260A patent/EP0850298B1/en not_active Expired - Lifetime
- 1996-09-12 AT AT96930260T patent/ATE242316T1/de not_active IP Right Cessation
- 1996-09-12 PT PT96930260T patent/PT850298E/pt unknown
- 1996-09-12 JP JP51175697A patent/JP4280872B2/ja not_active Expired - Lifetime
- 1996-09-12 RU RU98107327/14A patent/RU2185833C2/ru not_active IP Right Cessation
- 1996-09-12 CA CA002231436A patent/CA2231436C/en not_active Expired - Lifetime
- 1996-09-12 SK SK306-98A patent/SK285816B6/sk unknown
- 1996-09-12 CN CN96196376A patent/CN1193345A/zh active Pending
- 1996-09-12 KR KR1019980701856A patent/KR19990044606A/ko not_active Application Discontinuation
- 1996-09-12 HU HU9802091A patent/HUP9802091A3/hu unknown
-
1998
- 1998-03-11 NO NO981072A patent/NO981072L/no not_active Application Discontinuation
- 1998-08-19 HK HK98110007A patent/HK1009154A1/xx not_active IP Right Cessation
-
2001
- 2001-01-12 US US09/760,274 patent/US7048921B2/en not_active Expired - Fee Related
-
2003
- 2003-02-28 US US10/376,119 patent/US20030147873A1/en not_active Abandoned
-
2005
- 2005-07-08 US US11/178,216 patent/US7371374B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU6937596A (en) | 1997-04-01 |
JPH11513242A (ja) | 1999-11-16 |
PT850298E (pt) | 2003-09-30 |
US7048921B2 (en) | 2006-05-23 |
DE69628566T2 (de) | 2004-05-06 |
CA2231436C (en) | 2007-07-17 |
DK0850298T3 (da) | 2003-09-15 |
ES2196172T3 (es) | 2003-12-16 |
KR19990044606A (ko) | 1999-06-25 |
HK1009154A1 (en) | 1999-05-28 |
US7371374B2 (en) | 2008-05-13 |
EP0850298B1 (en) | 2003-06-04 |
JP4280872B2 (ja) | 2009-06-17 |
US20030147873A1 (en) | 2003-08-07 |
NO981072L (no) | 1998-05-12 |
SK285816B6 (sk) | 2007-09-06 |
WO1997010329A1 (en) | 1997-03-20 |
CA2231436A1 (en) | 1997-03-20 |
EP0850298A1 (en) | 1998-07-01 |
HUP9802091A3 (en) | 2001-01-29 |
CZ296669B6 (cs) | 2006-05-17 |
US20060051326A1 (en) | 2006-03-09 |
AU711563B2 (en) | 1999-10-14 |
SK30698A3 (en) | 1999-01-11 |
CN1193345A (zh) | 1998-09-16 |
GB9518606D0 (en) | 1995-11-15 |
RU2185833C2 (ru) | 2002-07-27 |
ATE242316T1 (de) | 2003-06-15 |
US20010001662A1 (en) | 2001-05-24 |
PL325646A1 (en) | 1998-08-03 |
PL186777B1 (pl) | 2004-02-27 |
NO981072D0 (no) | 1998-03-11 |
CZ55898A3 (cs) | 1998-06-17 |
DE69628566D1 (de) | 2003-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9802091A2 (hu) | Idegátültetés pluripotens neuroepiteliális sejtek alkalmazásával | |
EP0671920A4 (en) | AN ANTI-IDIOTYPICAL ANTIBODY AND ITS USE IN THE DIAGNOSIS AND THERAPY OF HIV-RELATED DISEASES. | |
DK0696205T3 (da) | Anvendelse af neuro-afledte fetale cellelinier til transplantationsterapi | |
AU1049788A (en) | Methods and peptides for the treatment of non-ige-mediated diseases | |
FR2810539B1 (fr) | Procede et dispositif de traitement,notamment de maquillage, de coloration ou de soin cosmetique,de parties ou de la totalite du corps humain ou animal | |
DE69822665D1 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
MX9801596A (es) | Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas. | |
DE69331605D1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
ES2063060T3 (es) | Benzamida contra enfermedades cognoscitivas. | |
TR200101149T2 (tr) | Dış retina bozukluklarının tedavisi. | |
AU1463088A (en) | Receptor of the small rhinovirus receptor group | |
LV11940A (lv) | Melatonina pielietojums personu arstesanai kuras cies no zalu atkaribas | |
DE69626816D1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
DK1133296T3 (da) | Ny terapeutisk anvendelse af nicergolin | |
DE3686019D1 (de) | Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten. | |
PT869785E (pt) | 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente | |
NO984651L (no) | Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet | |
DE3769497D1 (de) | Mittel zur bekaempfung von phytopathogenen mikroben. | |
NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
DE68909750D1 (de) | Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias. | |
TR199901385T2 (xx) | Piperidin t�revleri. | |
DE69712287D1 (de) | Verwendung von Sulbutiamin zur Behandlung von psychomotorischen oder psychointellektuellen Beschwerden | |
FR2818147B1 (fr) | Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine |